The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
The Pathophysiology of Fragile X Syndrome
Abstract
Fragile X syndrome is the most common form of inherited mental retardation. The disorder is mainly caused by the expansion of the trinucleotide sequence CGG located in the 5' UTR of the FMR1 gene on the X chromosome. The abnormal expansion of this triplet leads to hypermethylation and consequent silencing of the FMR1 gene. Thus, the absence of the encoded protein (FMRP) is the basis for the phenotype. FMRP is a selective RNA-binding protein that associates with polyribosomes and acts as a negative regulator of translation. FMRP appears to play an important role in synaptic plasticity by regulating the synthesis of proteins encoded by certain mRNAs localized in the dendrite. An advancing understanding of the pathophysiology of this disorder has led to promising strategies for pharmacologic interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The disorder is primarily caused by expansion of a CGG triplet repeat in the 5 ′ untranslated region of the fragile X mental retardation 1 ( FMR1 ) gene that cause a reduction of the FMR1 protein, although several other mutations in FMR1 have been described 90 .”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [90]
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Self-citationFu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Self-citationThe mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580
Self-citationInstability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Absence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Self-citationAltered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349
Self-citationStructure and function of dendritic spines
Nimchinsky, E. A., Sabatini, B. L., & Svoboda, K. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081501.160008 · Cited by 1,208
Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109
Self-citationFmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,108
Flagged first, then by citations
Research works printed but not linked: 12
- Ceman S, 1999, Cell. Biol., 19, 7925
- Dutch-Belgian Fragile X Consortium, 1994, Cell, 78, 23
- Fisch GS, 1995, Am. J. Hum. Genet., 56, 1147
- Lehrke RG, 1974, Birth Defects Orig. Artic. Ser., 10, 1
- Lubs HA, 1969, Am. J. Hum. Genet., 21, 231
- Martin J, 1943, Arch. Neurol. Psychiat., 6, 154
- Nolin SL, 1996, Am. J. Med. Genet., 59, 1252
- Penrose LS, 1938, Special Report Series, Medical Research Council 299
- Rousseau F, 1995, Am. J. Hum. Genet., 57, 1006
- Santoro N, 2003, Ann. Endocrinol., 64, 87
- Suthers GK, 1990, Am. J. Hum. Genet., 47, 187
- Wohrle D, 1992, Am. J. Hum. Genet., 51, 299
Cited by
Sorted by citations
Items 201–300 of 420
The role of glycogen synthase kinase-3 signaling in neurodevelopment and fragile X syndrome.
Portis, S. M., Giunta, B. N., Obregon, D. F., & Tan, J. (2012) · Europe PMC (PubMed Central) · Cited by 24
Simhal, A. K., Zuo, Y., Perez, M. M., Madison, D. V., Sapiro, G., & Micheva, K. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-50240-x · Cited by 24
Reducing glutamate signaling pays off in fragile X
Bassell, G. J., & Groß, C. (2008) · Nature Medicine · doi:10.1038/nm0308-249 · Cited by 24
Current Approaches to Epigenetic Therapy
Griazeva, E. D., Fedoseeva, D. M., Radion, E. I., Ershov, P. V., Meshkov, I. O., Semyanihina, A. V., Makarova, A. S., Makarov, V. V., Yudin, V. S., Keskinov, A. A., et al. (2023) · Epigenomes · doi:10.3390/epigenomes7040023 · Cited by 23
Functional consequences of postnatal interventions in a mouse model of Fragile X syndrome
Rais, M., Lovelace, J. W., Shuai, X. S., Woodard, W., Bishay, S., Estrada, L., Sharma, A. R., Nguy, A. K., Kulinich, A. O., Pirbhoy, P. S., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105577 · Cited by 25
Fragile X syndrome: An aging perspective
Schneider, A., Ligsay, A., & Hagerman, R. J. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1129 · Cited by 23
Xu, S., Poidevin, M., Han, E., Bi, J., & Jin, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037937 · Cited by 23
The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS)
Tassone, F., & Berry‐Kravis, E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5805-1 · Cited by 24
Fink, J. J., & Levine, E. S. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00237 · Cited by 26
Dopaminergic Perturbation in the Aetiology of Neurodevelopmental Disorders
Ijomone, O. K., Oria, R. S., Ijomone, O. M., Aschner, M., & Bornhorst, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04418-8 · Cited by 22
Parvin, S., Takeda, R., Sugiura, Y., Neyazaki, M., Nogi, T., & Sasaki, Y. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.09.013 · Cited by 22
Ricci, R., & Colasante, G. (2021) · Developmental Neuroscience · doi:10.1159/000515845 · Cited by 23
Hamada, A., Miyawaki, K., Honda‐Sumi, E., Tomioka, K., Mito, T., Ohuchi, H., & Noji, S. (2009) · Developmental Dynamics · doi:10.1002/dvdy.22029 · Cited by 22
Hyperexcitability of Sensory Neurons in Fragile X Mouse Model
Deng, P., Avraham, O., Cavalli, V., & Klyachko, V. A. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.796053 · Cited by 21
Group I Metabotropic Glutamate Receptors (mGluRs): Ins and Outs
Mahato, P. K., Ramsakha, N., Ojha, P., Gulia, R., Sharma, R. V., & Bhattacharyya, S. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3065-0_12 · Cited by 22
Transient Enhanced GluA2 Expression in Young Hippocampal Neurons of a Fragile X Mouse Model
Banke, T. G., & Barría, A. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.588295 · Cited by 20
Mutation Spectra in Fragile X Syndrome Induced by Deletions of CGG·CCG Repeats
Wells, R. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800024200 · Cited by 20
Evans, T. L., Blice‐Baum, A. C., & Mihailescu, M. (2011) · Molecular BioSystems · doi:10.1039/c1mb05322a · Cited by 20
Comorbidity landscape of the Danish patient population affected by chromosome abnormalities
Jørgensen, I. F., Russo, F., Jensen, A. B., Westergaard, D., Lademann, M., Hu, J. X., Brunak, S., & Belling, K. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0519-9 · Cited by 20
Involvement and Therapeutic Potential of the GABAergic System in the Fragile X Syndrome
Heulens, I., D’Hulst, C., Braat, S., Rooms, L., & Kooy, R. F. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.211 · Cited by 19
McAninch, D. S., Heinaman, A. M., Lang, C. N., Moss, K. R., Bassell, G. J., Mihailescu, M., & Evans, T. L. (2017) · Molecular BioSystems · doi:10.1039/c7mb00070g · Cited by 19
Reiner, B. C., & Dunaevsky, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126572 · Cited by 20
Pathophysiology of Epilepsy in Autism Spectrum Disorders
Stafstrom, C. E., Hagerman, P. J., & Pessah, I. N. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0071 · Cited by 19
Morè, L., Lauterborn, J. C., Papaleo, F., & Brambilla, R. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.02.003 · Cited by 20
Leboucher, A., Bermudez-Martin, P., Mouska, X., Amri, E., Pisani, D. F., & Davidovic, L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00678 · Cited by 19
Cheng, K., Chen, Y.-S., Yue, C., Zhang, S., Pei, Y.-P., Cheng, G.-R., Liu, D., Xu, L., Dong, H.-X., & Zeng, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01098 · Cited by 19
Myosin Va is required for the transport of fragile X mental retardation protein (FMRP) granules
Lindsay, A. J., & McCaffrey, M. (2013) · Biology of the Cell · doi:10.1111/boc.201200076 · Cited by 19
Klusek, J., LaFauci, G., Adayev, T., Brown, W. T., Tassone, F., & Roberts, J. E. (2017) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-017-9197-6 · Cited by 20
Splice form‐dependent regulation of axonal arbor complexity by FMRP
Zimmer, S. E., Doll, S. G., Garcia, A. D. R., & Akins, M. R. (2016) · Developmental Neurobiology · doi:10.1002/dneu.22453 · Cited by 17
Singh, K., & Prasad, S. (2008) · Biogerontology · doi:10.1007/s10522-008-9178-y · Cited by 18
Driesche, S. J. V., Sawicka, K., Zhang, C., Hung, K. Y. S., Park, C. Y., Fak, J. J., Yang, C., Darnell, R. B., & Darnell, J. C. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/762500 · Cited by 17
Abruzzi, K. C., Ratner, C., & Rosbash, M. (2023) · RNA · doi:10.1261/rna.079608.123 · Cited by 16
Meeting at the crossroads: common mechanisms in Fragile X and Down syndrome
Chang, K. T., Ro, H., Wang, W., & Min, K. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.08.007 · Cited by 17
Giráldez‐Pérez, R. M., Ávila, M. N., Feijoo‐Cuaresma, M., Heredia, R., de Diego‐Otero, Y., Real, M. A., & Guirado, S. (2012) · The Journal of Comparative Neurology · doi:10.1002/cne.23209 · Cited by 16
Weinshenker, D., & Warren, S. T. (2008) · Nature · doi:10.1038/455607a · Cited by 15
Self-citationMaussion, G., Rocha, C., Abdian, N., Yang, D., Turk, J., Valenzuela, D. C., Pimentel, L. S. B., You, Z., Morquette, B., Nicouleau, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914926 · Cited by 15
Kloetgen, A., Münch, P. C., Borkhardt, A., Hoell, J. I., & McHardy, A. C. (2014) · Briefings in Functional Genomics · doi:10.1093/bfgp/elu020 · Cited by 14
Role of FMRP in AKT/mTOR pathway-mediated hippocampal autophagy in fragile X syndrome
Zhang, B., Zhang, J., Chen, H., Qiao, D., Guo, F., Hu, X., Qin, C., Jin, X., Zhang, K., Wang, C., et al. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111036 · Cited by 16
Fogel, B. L., & Geschwind, D. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0434-1.00040-2 · Cited by 14
Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
Pignatelli, M., Feligioni, M., Piccinin, S., Molinaro, G., Nicoletti, F., & Nisticò, R. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319360008 · Cited by 14
Evans, T. L., & Mihailescu, M. (2010) · Protein Expression and Purification · doi:10.1016/j.pep.2010.06.002 · Cited by 14
Straub, D., Schmitt, L., Boggs, A. E., Horn, P. S., Dominick, K. C., Groß, C., & Erickson, C. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-29786-4 · Cited by 13
Fruitful research: drug target discovery for neurodegenerative diseases in Drosophila
Konsolaki, M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.849691 · Cited by 13
Perche, O., Lesne, F., Patat, A. A., Raab, S., Twyman, R. E., Ring, R. H., & Briault, S. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09375-0 · Cited by 13
Sourial, M. M., & Doering, L. C. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00126 · Cited by 13
Top-down or bottom-up: Contrasting perspectives on psychiatric diagnoses
Verhoeven, W. M. A., Egger, J. I. M., Gunning, W. B., M.Bevers, & de Pont, B. J. H. B. (2008) · Biologics · doi:10.2147/btt.s3053 · Cited by 15
Jacquemont, S., Birnbaum, S., Redler, S., Steinbach, P. J., & Biancalana, V. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.55 · Cited by 14
The Role of the Postsynaptic Density in the Pathology of the Fragile X Syndrome
Kindler, S., & Kreienkamp, H. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-21649-7_5 · Cited by 12
Cannon, B. L., Pan, C., Chen, L., Hadd, A. G., & Russell, R. (2012) · Molecular Biotechnology · doi:10.1007/s12033-012-9505-z · Cited by 12
Lu, Y. (2019) · Brain Research · doi:10.1016/j.brainres.2019.04.006 · Cited by 14
Single-Cell and Neuronal Network Alterations in an In Vitro Model of Fragile X Syndrome
Moskalyuk, A., Vijver, S. V. D., Verstraelen, P., Vos, W. H. D., Kooy, R. F., & Giugliano, M. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz068 · Cited by 12
Kim, S. W., & Cho, K. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.07.007 · Cited by 14
Brain Cholesterol Biosynthetic Pathway Is Altered in a Preclinical Model of Fragile X Syndrome
Parente, M., Tonini, C., Buzzelli, V., Carbone, E., Trezza, V., & Pallottini, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063408 · Cited by 11
“FMRP is an RNA-binding protein regulating mRNA translation, trafficking and stability [5].”
BackgroundPost‐Transcriptional Regulation of Gene Expression and the Intricate Life of Eukaryotic mRNAs
Lancaster, C. L., Moberg, K. H., & Corbett, A. H. (2025) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.70007 · Cited by 14
Autism spectrum disorder model mice: Focus on copy number variation and epigenetics
Nakai, N., Otsuka, S., Myung, J., & Takumi, T. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4891-7 · Cited by 11
Vandenberg, G. G., Thotakura, A., & Scott, A. L. M. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00130.2021 · Cited by 11
Across Dimensions: Developing 2D and 3D Human iPSC-Based Models of Fragile X Syndrome
Lee, A., Xu, J., Wen, Z., & Jin, P. (2022) · Cells · doi:10.3390/cells11111725 · Cited by 11
Interaction of USF1/USF2 and α-Pal/Nrf1 to Fmr-1 promoter increases in mouse brain during aging
Prasad, S., & Singh, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.155 · Cited by 11
Bauer, C. R., Epstein, A. M., Sweeney, S., Zarnescu, D. C., & Bosco, G. (2008) · BMC Systems Biology · doi:10.1186/1752-0509-2-101 · Cited by 11
Zito, A., & Lee, J. T. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2312757121 · Cited by 12
Mining and modeling human genetics for autism therapeutics
Smith, D. G., & Ehlers, M. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.03.004 · Cited by 10
Chemogenetic manipulation of astrocyte activity at the synapse— a gateway to manage brain disease
Pereira, M. J., Ayana, R., Holt, M. G., & Arckens, L. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1193130 · Cited by 10
Gong, X., Wang, Y., Zeng, J., Li, S., & Luo, Y. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1471-3 · Cited by 10
Increased iron content in the heart of the Fmr1 knockout mouse
Talvio, K., Kanninen, K. M., White, A. R., Koıstınaho, J., & Castrén, M. L. (2021) · BioMetals · doi:10.1007/s10534-021-00320-1 · Cited by 10
Cavani, S., Prontera, P., Grasso, M., Ardisia, C., Malacarne, M., Gradassi, C., Cecconi, M., Mencarelli, A., Donti, E., & Pierluigi, M. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33515 · Cited by 10
The Cerebellum and Autism: More than Motor Control
Fernández, M. C., Sierra-Arregui, T., & Peñagarikano, O. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85897 · Cited by 10
Chou, V., Johnson, S. A., Long, J. B., Vounatsos, M. V., & Vactor, D. V. (2019) · Cytoskeleton · doi:10.1002/cm.21578 · Cited by 7
The Endocannabinoid System in Prefrontal Synaptopathies
Scheyer, A. F., Martin, H. G. S., & Manzoni, O. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_7 · Cited by 10
Luque, M. A., Morcuende, S., Torres, B., & Herrero, L. (2024) · The Journal of Physiology · doi:10.1113/jp285244 · Cited by 9
Neocortical development as an evolutionary platform for intragenomic conflict
Lewitus, É., & Kalinka, A. T. (2013) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2013.00002 · Cited by 9
Impact of Chromatin Organization and Epigenetics on CRISPR-Cas and TALEN Genome Editing
Jain, S., Xun, G., & Zhao, H. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00099 · Cited by 9
Aligning Animal Models with Clinical Epilepsy: Where to Begin?
Harward, S. C., & McNamara, J. O. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-8914-1_19 · Cited by 9
Gaur, P., & Prasad, S. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3571-1 · Cited by 9
Familial mental retardation: a review and practical classification
Maris, A. F., Barbato, I. T., Trott, A., & Montano, M. A. E. (2013) · Ciência & Saúde Coletiva · doi:10.1590/s1413-81232013000600023 · Cited by 11
Sakano, H., Zorio, D. A. R., Wang, X., Ting, Y. S., Noble, W. S., MacCoss, M. J., Rubel, E. W., & Wang, Y. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24281 · Cited by 8
Zhao, W., Wang, J., Song, S., Li, F., & Yuan, F. (2015) · Europe PMC (PubMed Central) · Cited by 8
Diverse Functions and Mechanisms of Mammalian Long Noncoding RNAs
Merry, C. R., Niland, C. N., & Khalil, A. M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1369-5_1 · Cited by 9
Mutated Human Embryonic Stem Cells for the Study of Human Genetic Disorders
Ben‐Yehudah, A., Malcov, M., Frumkin, T., & Ben‐Yosef, D. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-794-1_11 · Cited by 8
Kinney, H. C., & Volpe, J. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42876-7.00007-7 · Cited by 8
Mental Retardation: Definition, Classification and Etiology
Regan, R., & Willatt, L. R. (2010) · Monographs in human genetics · doi:10.1159/000287593 · Cited by 13
De Novo Large Deletion Leading to Fragile X Syndrome
Jiraanont, P., Manor, E., Tabatadze, N., Zafarullah, M., Mendoza‐Morales, G., Melikishvili, G., & Tassone, F. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.884424 · Cited by 7
Evidence for parent-of-origin effects in autism spectrum disorder: a narrative review
Ryan, N., & Heron, E. A. (2023) · Journal of Applied Genetics · doi:10.1007/s13353-022-00742-8 · Cited by 8
Deregulation of RNA Metabolism in Microsatellite Expansion Diseases
Misra, C., Lin, F., & Kalsotra, A. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_8 · Cited by 7
Yu, X.-Y., Wang, X.-Y., Sakano, H., Zorio, D., & Wang, Y. (2020) · The Journal of comparative neurology · doi:10.1002/cne.24959 · Cited by 7
Astrocytic GABA controls fidelity of temporal cortical processing in Fragile X Syndrome
Wagner, V. A., Thapa, R., Norman, A. O., Varallo, A., Wimberly, J., Rais, M., Gerasymchuk, D., Piepponen, P. T., Razak, K. A., Castrén, M. L., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107233 · Cited by 8
Prasad, S., & Singh, K. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9545-0 · Cited by 5
Wang, X., Fan, Q., Yu, X., & Wang, Y. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25420 · Cited by 5
Viveiros, M. T. M., Santos, M., dos Santos, J. M., Viveiros, D. M., Cavalcante, M. R. M., Caldas, A. J. M., & Pimentel, M. M. G. (2015) · Genetics and Molecular Research · doi:10.4238/2015.june.18.32 · Cited by 6
Meng, Y., Hu, Y., Xue, Y., & Zhen, Z. (2025) · Metabolites · doi:10.3390/metabo15020134 · Cited by 3
Dougnon, G., & Matsui, H. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03741-5 · Cited by 3
Geng, J., Wang, X., Pan, J., Khan, D., Pimcharoen, S., Zhang, Y., Mosammaparast, N., Hirose, S., Petrucelli, L., Brandman, O., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq3551 · Cited by 4
Arrieta, M., Ramírez, J., Télez, M., Flores, P., Criado, M. B., Barasoain, M., Huerta, I., & Gonzalez, A. (2008) · Current Genomics · doi:10.2174/138920208784340722 · Cited by 4
Crum-Bailey, J., Dennison, D. H., Weiner, W. J., & Hawley, J. S. (2013) · Future Neurology · doi:10.2217/fnl.12.92 · Cited by 4
Pharmacological Treatments for Fragile X Syndrome Based on Synaptic Dysfunction
Telias, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191102165206 · Cited by 4
MicroRNA-Mediated Regulation and the Genetic Susceptibility to Anxiety Disorders
Espinosa‐Parrilla, Y., & Muiños-Gimeno, M. (2011) · InTech eBooks · doi:10.5772/21702 · Cited by 4
Suresh, A., Kourdougli, N., Nomura, T., Buth, J. E., Miranda‐Rottmann, S., Sánchez-León, C. A., Wu, M. W., Nelson, S. M., Wall, L. T., Tran, A., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.032 · Cited by 3
Shi, L., Kosti, A., Raj, N., Sun, J., Gao, Y., Simamora, R. C., Valdez‐Sinon, A. N., Faúndez, V., & Bassell, G. J. (2025) · iScience · doi:10.1016/j.isci.2025.113062 · Cited by 3
Zhang, Z., Keyser, C., Li, Y., Rosolia, B. J., Porch, M. W., Zhang, W., Su, B., Peng, J. C., Zukin, R. S., & Yan, J. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03207-6 · Cited by 3
FMR1gene mutation screening by TP-PCR in patients with premature ovarian failure and fragile-X
Tural, Ş., Tekcan, A., Kara, N., Elbistan, M., Güven, D., & Taşdemir, H. A. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.975685 · Cited by 3
Neuroligins and Neurexins: Synaptic Bridges Implicated in Autism
Powell, C. M., & Boucard, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1272-5_13 · Cited by 3
Metadata
- Authors
- Penagarikano, O., Mulle, J. G., & Warren, S. T.
- Affiliations
- Department of Human Genetics, 2Department of Biochemistry and 3Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322;, ,
- Emory University (US)
- Venue
- Annual Review of Genomics and Human Genetics
- Publisher
- Annual Reviews
- Published
- 2007-09-01
- Volume
- 8
- Issue
- 1
- Pages
- 109-129
- ISSN
- 1527-8204 (ISSN-L)
- 1545-293X
- OpenAlex
- W2141296384
- Cited by
- 420
- References
- 133
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 10 · 2023: 11 · 2022: 11 · 2021: 19 · 2020: 14 · 2019: 26 · 2018: 21 · 2017: 20 · 2016: 24 · 2015: 24 · 2014: 32 · 2013: 27 · 2012: 39
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Genomics and Human Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- fragile X syndrome, FMR1 gene, CGG repeat expansion, FMRP, RNA-binding proteins, translational regulation, synaptic plasticity, dendritic mRNA localization, epigenetic silencing, hypermethylation, intellectual disability, pathophysiology, pharmacological interventions
- MeSH terms
- Base Sequence, Fragile X Syndrome, Humans, Models, Biological, Molecular Sequence Data, Mutation, Neurons, Nucleic Acid Conformation, Trinucleotide Repeats, Inheritance Patterns, Chromosomes, Human, X, Fragile X Messenger Ribonucleoprotein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review